Funder
National Health Research Institutes
MOST
Ministry of Science and Technology
Ministry of Science and Technology, Taiwan
Reference265 articles.
1. Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: a randomized, double-blind, placebo-controlled, dose-titration trial;Wagner;Muscle Nerve,2021
2. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis;Adams;N. Engl. J. Med.,2018
3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021
4. Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity;Amodio;Leukemia,2018
5. Immune escape mechanisms as a guide for cancer immunotherapy;Beatty;Clin. Cancer Res.,2015